Fabtech Technologies Quarterly Results for Trading Insights
FABTECH • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹28 Cr
QSept 2025
Fabtech Technologies Quarterly Results Key Highlights
- Revenue of ₹125 Cr in Sept 2025 (-9.4% vs Mar 2025, +104.9% vs Sept 2024)
- Net Profit of ₹28 Cr in Sept 2025 (+86.7% vs Mar 2025, +460.0% vs Sept 2024)
- EBITDA of ₹34 Cr in Sept 2025 (+54.5% vs Mar 2025)
- Operating Margin of 25.0% in Sept 2025 (+11.0pp vs Mar 2025)
- Earnings Per Share of ₹8.68 in Sept 2025 (+86.3% vs Mar 2025)
Fabtech Technologies Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 125 | 138 | 71 | 70 | 61 | -9.4% | 104.9% |
| Net Profit (₹ Cr) | 28 | 15 | -6 | -6 | 5 | - | - |
| EBITDA (₹ Cr) | 34 | 22 | -4 | -5 | 7 | - | - |
| EPS (₹) | 8.68 | 4.66 | -1.89 | -1.56 | 1.58 | - | - |
| Operating Margin (%) | 25.0% | 14.0% | -9.0% | -18.0% | 8.0% | - | - |
Fabtech Technologies Share Price Trend Around Quarterly Results
Visualize Fabtech Technologies's 1-year price movement across quarterly results — ideal for logging trades in Fabtech Technologies share price
chart using Tickjournal. All values in ₹.
Related Pages for Fabtech Technologies
Additional stock information and data for FABTECH
Revenue Trend (₹ Cr)
Dec 2025
70
Jun 2025
71
Mar 2025
138
Sept 2025
125
Net Profit Trend (₹ Cr)
Dec 2025
-6
Jun 2025
-6
Mar 2025
15
Sept 2025
28
Operating Margin Trend (%)
Dec 2025
-18.0%
Jun 2025
-9.0%
Mar 2025
14.0%
Sept 2025
25.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Fabtech Technologies quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹416,764.48 Cr | 1752.5 | 14,875 | 3,125 | +10.8% | - | 21.0% | 134.8 |
|
Divis Laboratories
Sept 2025 |
₹170,125.54 Cr | 6403.5 | 2,860 | 689 | +7.1% | - | 24.1% | 246.6 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹146,658.56 Cr | 4369.2 | 3,219 | 591 | +11.3% | - | 18.4% | 249.1 |
|
Cipla
Sept 2025 |
₹109,178.44 Cr | 1351.6 | 7,716 | 1,353 | +12.0% | - | 17.5% | 80.8 |
|
Dr Reddys Laborator…
Sept 2025 |
₹107,358.50 Cr | 1294.4 | 9,135 | 1,337 | +1.1% | - | 14.6% | 80.0 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores